Search Results 1151-1160 of 17703 for corticosteroid

1. A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma - Mayo Clinic

   Immunosuppressive therapy includes but is not limited to cyclosporine A, tacrolimus, or high-dose corticosteroids. Subjects receiving corticosteroids must ...

2. Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery - Mayo Clinic

   No patients receiving systemic corticosteroids (either intravenous [IV] or oral steroids, excluding inhalers or low-dose hormone replacement therapy) within ...

3. A Study of Idelalisib Combined with BI 836826 for Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

   If on a systemic corticosteroid, the dose must be stable for the previous 4 weeks ... Ongoing systemic immunosuppressive therapy other than corticosteroids ...

4. Intensive Care Clinical Trials - Mayo Clinic Research

   ... corticosteroids for community acquired pneumonia. Patients with severe community acquired pneumonia may benefit from adjunctive corticosteroid therapy. The ...

5. Bendamustine Hydrochloride and Rituximab with or without Bortezomib Followed by Rituximab with or without Lenalidomide in Treating Patients with High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma - Mayo Clinic

   Prednisone or other corticosteroids used for non-lymphomatous conditions will not be considered as prior chemotherapy; A prior/recent short course (< 2 weeks) ...

6. A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib to To Treat Newly-diagnosed AML with or without FLT3 Mutations - Mayo Clinic

   - Corticosteroids (any route) - Intrathecal therapy given at diagnosis - In particular, strong inducers of CYP3A4 and/or P-glycoprotein (P-gp) should be

7. Cabozantinib and Nivolumab in Treating Patients With Advanced, Recurrent or Metastatic Endometrial Cancer - Mayo Clinic

   ... corticosteroids at physiologic dose not to exceed 10 mg/day of ... corticosteroid replacement therapy for adrenal or pituitary insufficiency, etc.) ...

8. Publications - Natalya Azadeh, M.D. - Mayo Clinic

   Epub 2014 Jun 11. View PubMed; Azadeh N, Chang YH, Kusne S, Vikram HR, Seville MT, Orenstein R, Blair JE. The impact of early and brief corticosteroids on the ...

9. Phase ll Study of Pirfenidone in Patients With RAILD - Mayo Clinic

   ... corticosteroids that are maintained at or below 20 mg prednisone daily or the equivalent. However, introduction and/or modification of dose of corticosteroids ...

10. A Study of Taxane, Trastuzumab, and Pertuzumab With or Without Atezolizumab in Treating Metastatic Breast Cancer Patients - Mayo Clinic

    Note: Intranasal and inhaled corticosteroids or systemic corticosteroids at doses that do not exceed 10 mg/day of prednisone or an equivalent corticosteroid are ...